Worldwide Market for Cancer Diagnostics, 4th Edition, Now Available at ReportsandReports
Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease.
Dallas, TX, April 28, 2010 --(PR.com)-- ReportsandReports Announce it Will Carry Worldwide Market for Cancer Diagnostics, 4th Edition, The Market Research Report in its Store.
Browse the complete Report on: http://www.reportsandreports.com/market-reports/worldwide-market-for-cancer-diagnostics-4th-edition-the/
Since Kalorama Information last updated comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some companies who promised much in the past have not produced results. And new entrants have entered the field.
These changes and more are addressed in Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th. Edition. This report authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for their use in cancer diagnostics:
• Histology/Cytology
• Immunoassays
• Flow Cytometry
• Rapid Tests
• Molecular Assays
• Tissue Arrays
• Circulating Tumor Cells
• Pharmacodiagnostics
Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease. Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th Edition represents the fourth time Kalorama has engaged in an exhaustive study on the status of this important diagnostic market. Among the market data provided in this report, readers will find:
• Immunoassay Lab Based Cancer Test Sales
• Pap Smear Testing Volumes
• World Cancer Statistics
• POC Tests
• DNA Reagents for Cancer Testing
• CTC Testing Markets
• Biochip Innovations
• New Companies with Novel Approaches
• "Laggard" Companies Who Have Not Met Expectations
• Major Protein and Molecular Markers Used in Tissue Staining
• Biomarkers Under Investigation
• Acquisitions and Mergers
• Status of PGx Testing
• Microarray Markets in Clinical Labs
• Lists of Vendors and Major Products
• Unmet Needs of the Marketplace
This report includes market analysis of the following screening tests: The Cancer Profile, CTC, Fecal Occult Blood, PSA, H. pylori, IHC, ISH As well as tests for specific cancers:
• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colon Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer
This latest edition of Kalorama Information’s study takes a fresh look at all of these developments both qualitatively and quantitatively. The report provides revenue and growth forecasts through 2014 and, as in the previous edition, analyzes the market in two ways:
• Tests for specific cancers, and
• Cancer tests in specific IVD segments
This allows the reader to match his or her own situation to the market at large.
Table Of Contents
Chapter One: Executive Summary
Chapter Three: Market Trends In The Commercialization Of Cancer Diagnostics
Chapter Four: Technological Trends
Chapter Five: Market Analysis
Chapter Six: Cancer Tests In Ivd Segments (Segment Analysis)
Chapter Seven: Conclusions
Chapter Eight: The Top Tier Of Ivd Companies And Their Investment In
Cancer Diagnostics
Chapter Nine: The Status Quo In Cancer Diagnostics
Chapter Ten: New Entrants And Novel Product Developers
Related Reports:
Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth
http://www.reportsandreports.com/market-reports/pipeline-insight-small-molecule-targeted-cancer-therapies-new-/
Top 20 Cancer Therapy Brands in Australia Forecast
http://www.reportsandreports.com/market-reports/top-20-cancer-therapy-brands-in-australia-forecast/
The Cancer Market Outlook To 2014: Competitive landscape, market size, pipeline analysis and growth opportunities
http://www.reportsandreports.com/market-reports/the-cancer-market-outlook-to-2014-competitive-landscape-market-/
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
###
Browse the complete Report on: http://www.reportsandreports.com/market-reports/worldwide-market-for-cancer-diagnostics-4th-edition-the/
Since Kalorama Information last updated comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some companies who promised much in the past have not produced results. And new entrants have entered the field.
These changes and more are addressed in Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th. Edition. This report authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for their use in cancer diagnostics:
• Histology/Cytology
• Immunoassays
• Flow Cytometry
• Rapid Tests
• Molecular Assays
• Tissue Arrays
• Circulating Tumor Cells
• Pharmacodiagnostics
Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease. Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th Edition represents the fourth time Kalorama has engaged in an exhaustive study on the status of this important diagnostic market. Among the market data provided in this report, readers will find:
• Immunoassay Lab Based Cancer Test Sales
• Pap Smear Testing Volumes
• World Cancer Statistics
• POC Tests
• DNA Reagents for Cancer Testing
• CTC Testing Markets
• Biochip Innovations
• New Companies with Novel Approaches
• "Laggard" Companies Who Have Not Met Expectations
• Major Protein and Molecular Markers Used in Tissue Staining
• Biomarkers Under Investigation
• Acquisitions and Mergers
• Status of PGx Testing
• Microarray Markets in Clinical Labs
• Lists of Vendors and Major Products
• Unmet Needs of the Marketplace
This report includes market analysis of the following screening tests: The Cancer Profile, CTC, Fecal Occult Blood, PSA, H. pylori, IHC, ISH As well as tests for specific cancers:
• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colon Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer
This latest edition of Kalorama Information’s study takes a fresh look at all of these developments both qualitatively and quantitatively. The report provides revenue and growth forecasts through 2014 and, as in the previous edition, analyzes the market in two ways:
• Tests for specific cancers, and
• Cancer tests in specific IVD segments
This allows the reader to match his or her own situation to the market at large.
Table Of Contents
Chapter One: Executive Summary
Chapter Three: Market Trends In The Commercialization Of Cancer Diagnostics
Chapter Four: Technological Trends
Chapter Five: Market Analysis
Chapter Six: Cancer Tests In Ivd Segments (Segment Analysis)
Chapter Seven: Conclusions
Chapter Eight: The Top Tier Of Ivd Companies And Their Investment In
Cancer Diagnostics
Chapter Nine: The Status Quo In Cancer Diagnostics
Chapter Ten: New Entrants And Novel Product Developers
Related Reports:
Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth
http://www.reportsandreports.com/market-reports/pipeline-insight-small-molecule-targeted-cancer-therapies-new-/
Top 20 Cancer Therapy Brands in Australia Forecast
http://www.reportsandreports.com/market-reports/top-20-cancer-therapy-brands-in-australia-forecast/
The Cancer Market Outlook To 2014: Competitive landscape, market size, pipeline analysis and growth opportunities
http://www.reportsandreports.com/market-reports/the-cancer-market-outlook-to-2014-competitive-landscape-market-/
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
###
Contact
ReportsandReports
Sunita Christ
+1-888-989-8004
http://www.reportsandreports.com
Sunita Christ
+1-888-989-8004
http://www.reportsandreports.com
Contact
Categories